SCHEMBL4553968

SCHEMBL4553968

Cc1cccc(F)c1C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.50
CYP1A2 P05177 1/20 0.36
CYP2A6 P11509 1/20 0.36
TRPA1 O75762 2/20 0.36
ATM Q13315 1/20 0.36
TSHR P16473 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HSD11B1 P28845 2/20 0.34
HCAR1 Q9BXC0 1/20 0.34
SCN9A Q15858 1/20 0.33
P2RX7 Q99572 1/20 0.33
ELANE P08246 2/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24105727 0.86 ACHE (0.50) ACHECYP1A2CYP2A6TRPA1ATM
SCHEMBL4090283 0.85 CYP2A6 (0.43) ACHECYP1A2CYP2A6TRPA1ATM
SCHEMBL22989913 0.84 ACHE (0.48) ACHECYP1A2CYP2A6TRPA1ATM
SCHEMBL1541726 0.82 TRPA1 (0.40) ACHETRPA1TSHRALDH1A1HSD11B1
SCHEMBL803441 0.81 ACHE (0.50) ACHECYP1A2CYP2A6TRPA1ATM
SCHEMBL28179752 0.78 TRPA1 (0.42) ACHECYP1A2CYP2A6TRPA1ATM
SCHEMBL3668657 0.77 ACHE (0.46) ACHECYP1A2CYP2A6TRPA1ATM
SCHEMBL6629394 0.76 HSD11B1 (0.47) ACHECYP1A2CYP2A6TRPA1ATM
SCHEMBL942704 0.76 CYP2A6 (0.36) ACHECYP1A2CYP2A6TRPA1ATM
SCHEMBL22024000 0.76 ACHE (0.44) ACHECYP1A2CYP2A6TRPA1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
WO-2024077391-A1 THIAZOLO[5,4-D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF UNIVERSITE DE MONTREAL (CA) 2024-04-18 WO disclosed
EP-4227307-A1 PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS Genzyme Corporation (US) 2023-08-16 EP disclosed
WO-2023150394-A1 METHODS FOR TREATMENT OF CANCER FRONTIER MEDICINES CORPORATION (US) 2023-08-10 WO disclosed
WO-2023114954-A1 PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS GENZYME CORPORATION (US) 2023-06-22 WO disclosed
WO-2023284730-A1 ALKYLIDENE DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2023-01-19 WO disclosed
EP-3476854-B1 ANTIVIRAL PRECURSOR DRUG NUCLEOSIDE CYCLOPHOSPHATE COMPOUND AND USE THEREOF ZHEJIANG PALOALTO PHARMACEUTICAL TECH CO LTD (CN) 2021-05-12 EP disclosed
WO-2021063346-A1 KRAS G12C INHIBITOR AND APPLICATION THEREOF 上海迪诺医药科技有限公司 2021-04-08 WO disclosed
US-20210040089-A1 KRAS MUTANT PROTEIN INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. 2021-02-11 US disclosed
US-7517995-B2 Thiazolyl-dihydro-cyclopentapyrazole BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-14 US disclosed
US-20080312085-A1 Pesticidal Compositions BASF SE (DE) 2008-12-18 US disclosed
US-20080312085-A1 Pesticidal Compositions BASF SE (DE) 2008-12-18 US disclosed
WO-2007147701-A1 AZOLINE COMPOUNDS FOR COMBATING ARTHROPOD PESTS BASF SE (DE) 2007-12-27 WO disclosed
US-20070238730-A1 THIAZOLYL-DIHYDRO-CYCLOPENTAPYRAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-11 US disclosed
WO-2007071585-A1 PESTCIDAL COMPOSITIONS BASF SE (DE) 2007-06-28 WO disclosed
US-20060160786-A1 Substituted triazole derivatives as oxytocin antagonists PFIZER INC 2006-07-20 US disclosed
EP-0285324-B1 PREPARATION OF SUBSTITUTED FLUOROBENZENES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-11-27 EP disclosed
EP-0285324-A1 Preparation of substituted fluorobenzenes E.I. DU PONT DE NEMOURS AND COMPANY (US) 1988-10-05 EP disclosed
US-4754084-A PYROLYSIS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NRAS, BRAF, KRAS ACHE 4868/4885CYP1A2 2650/4885CYP2A6 2110/4885
US-20060160786-A1 Substituted triazole derivatives as oxytocin antagonists OXTR, AVPR1B, GNRHR ACHE 1261/4885CYP1A2 1140/4885CYP2A6 2742/4885
US-20210040089-A1 KRAS MUTANT PROTEIN INHIBITORS KRAS, NRAS, APC ACHE 4787/4885CYP1A2 4199/4885CYP2A6 4153/4885
US-20070238730-A1 THIAZOLYL-DIHYDRO-CYCLOPENTAPYRAZOLE REN, ROR1, RORB ACHE 1324/4885CYP1A2 54/4885CYP2A6 297/4885
US-20080312085-A1 Pesticidal Compositions ANXA1, PRDX1, PRDX2 ACHE 119/4885CYP1A2 144/4885CYP2A6 1012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.